BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21697328)

  • 1. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.
    Dubberke ER; Han Z; Bobo L; Hink T; Lawrence B; Copper S; Hoppe-Bauer J; Burnham CA; Dunne WM
    J Clin Microbiol; 2011 Aug; 49(8):2887-93. PubMed ID: 21697328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.
    Boyanton BL; Sural P; Loomis CR; Pesta C; Gonzalez-Krellwitz L; Robinson-Dunn B; Riska P
    J Clin Microbiol; 2012 Mar; 50(3):640-5. PubMed ID: 22189114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory diagnosis of Clostridium difficile infection: Comparison of Techlab C. diff Quik Chek Complete, Xpert C. difficile, and multistep algorithmic approach.
    Seo JY; Jeong JH; Kim KH; Ahn JY; Park PW; Seo YH
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28177534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.
    Kvach EJ; Ferguson D; Riska PF; Landry ML
    J Clin Microbiol; 2010 Jan; 48(1):109-14. PubMed ID: 19864479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.
    Peterson LR; Young SA; Davis TE; Wang ZX; Duncan J; Noutsios C; Liesenfeld O; Osiecki JC; Lewinski MA
    J Clin Microbiol; 2017 Dec; 55(12):3426-3436. PubMed ID: 28954901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies.
    Hart J; Putsathit P; Knight DR; Sammels L; Riley TV; Keil A
    Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1555-64. PubMed ID: 24781004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
    Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER
    J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of five assays for detection of Clostridium difficile toxin.
    Chapin KC; Dickenson RA; Wu F; Andrea SB
    J Mol Diagn; 2011 Jul; 13(4):395-400. PubMed ID: 21704273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea.
    Dubberke ER; Reske KA; Hink T; Kwon JH; Cass C; Bongu J; Burnham CD; Henderson JP
    Infect Control Hosp Epidemiol; 2018 Nov; 39(11):1330-1333. PubMed ID: 30226126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM; Uslan DZ; Rubin Z
    J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays.
    Pancholi P; Kelly C; Raczkowski M; Balada-Llasat JM
    J Clin Microbiol; 2012 Apr; 50(4):1331-5. PubMed ID: 22278839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter clinical evaluation of the portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens.
    Buchan BW; Mackey TL; Daly JA; Alger G; Denys GA; Peterson LR; Kehl SC; Ledeboer NA
    J Clin Microbiol; 2012 Dec; 50(12):3932-6. PubMed ID: 23015667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?
    Ford CD; Lopansri BK; Coombs J; Webb BJ; Asch J; Hoda D
    Transpl Infect Dis; 2020 Aug; 22(4):e13279. PubMed ID: 32196881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rectal swabs and fecal samples for the detection of
    Huletsky A; Loo VG; Longtin Y; Longtin J; Trottier S; Tremblay CL; Gilca R; Lavallée C; Brochu É; Bérubé È; Bastien M; Bernier M; Gagnon M; Frenette J; Bestman-Smith J; Deschênes L; Bergeron MG
    Microbiol Spectr; 2024 Jun; 12(6):e0022524. PubMed ID: 38687067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.
    Stamper PD; Alcabasa R; Aird D; Babiker W; Wehrlin J; Ikpeama I; Carroll KC
    J Clin Microbiol; 2009 Feb; 47(2):373-8. PubMed ID: 19073875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a nucleic acid amplification assay for the diagnosis of Clostridioides difficile infection.
    Koyuncu-Ozyurt O; Ozhak B; Ogunc D; Ongut G; Gunseren F; Donmez L; Colak D
    Anaerobe; 2019 Oct; 59():201-204. PubMed ID: 31255716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
    J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.
    Deak E; Miller SA; Humphries RM
    J Clin Microbiol; 2014 Mar; 52(3):960-3. PubMed ID: 24352999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.